Urinary Flora: An Encyclopedic Reference in Nutrition and Natural-Health Context
1. Definition and Conceptual Overview
Urinary flora — also referred to as the urinary microbiome, urobiome, or urinary microbiota — describes the community of microorganisms that inhabit the human urinary tract under normal physiological conditions. The urinary tract hosts its own unique community of microorganisms known as the urinary microbiome. The term "microbiome" refers to the group of microbial genomes in a specific environment.
For most of the twentieth century, urine was considered sterile. Initially, the urinary bladder was not included in the Human Microbiome Project because urine was traditionally considered sterile due to the assumption of pathogenicity for all bacteria; however, the development of high-throughput DNA sequencing techniques has led to the identification of the commensal microbial community in the urinary tract. It has now been found that healthy people have a resident microbiota of normal flora in their urinary tract, dispelling the old belief that finding microorganisms in urine meant an infection.
The application of next-generation sequencing techniques has allowed the characterization of the urinary tract microbiome and has led to the rejection of the pre-established concept of sterility in the urinary bladder. Not only have microbial communities in the urinary tract been implicated in the maintenance of health, but alterations in their composition have also been associated with different urinary pathologies, such as urinary tract infections.
2. Body Systems Involved
The urinary flora is primarily associated with structures of the lower urinary tract. The term "microbiome" refers to the collection of microorganisms that inhabit a particular environment, including bacteria, viruses, fungi, and their genetic material; in the context of the urinary tract, the microbiome consists primarily of bacteria that live in the bladder and urethra.
The urinary flora does not exist in isolation. There are well-documented connections to the vaginal microbiome, the gut microbiome, the immune system, and the endocrine system:
- Vaginal–urinary axis: The anatomical proximity between the vagina and the urinary tract suggests that the vagina might be the main source of the urinary microbial community. Two recent reports have proposed that the female urinary microbiota and the vaginal microbiota are interconnected.
- Gut–urinary axis: The relationship between the gut microbiome and urinary tract health is more interconnected than expected. The gut serves as a reservoir for both beneficial and harmful bacteria, and imbalances in intestinal flora can affect the urinary tract.
- Immune system: A healthy urinary microbiome acts as a barrier against pathogens that can cause infections, such as urinary tract infections. Beneficial bacteria in the urinary tract can compete with harmful bacteria for resources, produce substances that inhibit pathogen growth, and stimulate the immune system to respond to potential threats.
- Endocrine system: As estrogen levels decrease in menopause, changes occur in the local urogenital tract that include thinning of the vaginal epithelium, an increase in pH, and an alteration of the composition of the local bacterial community, including a decrease in the typically predominant species of bacteria, lactobacilli.
3. Composition of Healthy Urinary Flora
The urinary microbiome is a dynamic ecosystem, and its composition can vary from person to person. It is comparatively low in biomass relative to other body sites. Recent advances in the analysis of microbial communities colonizing the human body have identified a resident microbial community in the human urinary tract. Compared to many other microbial niches, the human urinary tract harbors a relatively low biomass. Studies have identified many genera and species that may constitute a core urinary microbiome.
3.1 In Women
The most abundant genus found in the urinary microbiome of healthy women is Lactobacillus. Lactobacillus is an acid-producing, facultative anaerobic bacterium known to play protective roles in the vaginal tract by decreasing the pH and producing various bacteriostatic/bactericidal compounds. The second most frequently isolated bacterial strain in the urine of healthy women is Gardnerella, with Gardnerella vaginalis representing the most abundant species. Beside Lactobacillus and Gardnerella, other urotypes identified in the urinary microbiome of healthy females include Prevotella, Corynebacterium, Sneathia, Streptococcus, and Escherichia urotypes.
Within Lactobacillus, specific species have been identified. Bifidobacterium subtile, Lactobacillus crispatus, and Lactobacillus johnsonii were more predominant in females, as were the genera Bifidobacterium, Staphylococcus, Lactobacillus, and Corynebacterium. Studies of the healthy (asymptomatic) bladder microbiome have shown that it is frequently predominated by lactobacilli. Likewise, the healthy vaginal community typically consists of more than 70% lactobacilli, and reduced Lactobacillus in the vaginal community often coincides with bacterial imbalance.
Sex differences in the urinary microbiome are notable. Differences between women were associated with age, menopausal status, vaginal parity, and vaginal intercourse. Similar to Lactobacillus being the main genus in the female urinary microbiota, the male microbiota is characterized by the predominance of Corynebacterium and Streptococcus.
3.2 Urinary Composition and Ecological Pressures
Even the nitrates in the slightly acidic environment inhibit the growth of some uro-pathogenic bacteria, but there are also proteins with antimicrobial activity. The continued removal of urine from the organism does not favor the growth of microorganisms. All microorganisms that survive under these conditions must have developed special adaptation mechanisms.
Variation of the urinary microbiome between females and males may also stem from the different compositions in their urine. Women produce higher amounts of citrate but less calcium and oxalate, whereas males excrete more creatinine.
4. Urinary Flora Dysbiosis: Definition and How It Presents
The concept of "dysbiosis" — a change in abundance, gain, or loss of microbes in a community leading to an "imbalance" — has gained attention due to its potential link to disease. Dysbiosis of the microbiome manifests with one or more of the following characteristics: an increase in the proportion of pathogenic microorganisms, a decrease in the numbers of commensal microorganisms, and a reduction in microbial diversity.
Studies have shown that alterations in the composition and diversity of the urinary microbiome are closely related to chronic inflammation, immune dysregulation, metabolic disturbances, and changes in the local microenvironment.
Conditions associated with urinary flora dysbiosis include:
- Urinary tract infections (UTIs): The contribution of the urinary tract microbiome to UTI and recurrent UTI pathobiology is not yet clearly understood. Evidence suggests that commensal species within the urinary tract and urogenital tract microbiomes, such as Lactobacillus crispatus, may act to protect against colonization with uropathogens.
- Overactive bladder and urge urinary incontinence: Alterations in the urinary microbiome, known as dysbiosis, have been linked to conditions such as overactive bladder, urgency urinary incontinence, and recurrent urinary tract infections.
- Interstitial cystitis / bladder pain syndrome: A dysbiosis of the urinary microbiome is associated with urgency and urinary incontinence and also related to interstitial cystitis/bladder pain syndrome and neuropathic bladder.
- Bladder cancer: Resident urinary microbiota may contribute to bladder carcinogenesis by triggering persistent inflammation or producing bioactive metabolites. Compared with healthy individuals, patients with bladder cancer exhibit a characteristic dysbiosis of the urinary microbiome, with distinct compositional alterations that may be associated with tumor initiation, progression, therapeutic response, and diagnostic classification.
- Benign prostatic hyperplasia (BPH): Dysbiosis of the urinary microbiome may influence the local immune microenvironment and play a role in disease progression in BPH. Current studies have shown that the alpha diversity of the urinary microbiota in BPH patients is significantly higher than that of individuals without BPH.
- Urinary stone disease: Multiple factors have been associated with urinary stone disease, including socioeconomic status, host genetics, diet, pharmaceuticals, antibiotics, and metabolism. The microbiome is strongly associated with all of these factors and is thus implicated as an important mediator of the disease.
- Genitourinary syndrome of menopause: Vaginal dysbiosis — hallmarked by a shift in Lactobacillus profiles — is linked to urinary urgency, incontinence, interstitial cystitis with bladder pain syndrome, and neuropathic bladder, comprising the genitourinary syndrome of menopause.
5. Contributing and Associated Factors
The onset of dysbiosis is governed by environmental and host-related factors ranging from diet, infection, inflammation, antibiotic use, and genetics. Factors such as age, gender, sexual activity, antibiotic use, and underlying health conditions can all influence the makeup of the urinary microbiome.
5.1 Antibiotic Use
It has been widely studied that the antibiotics used against UTI might affect the gut microbiota, causing a reduction in abundance and diversity and, therefore, intestinal dysbiosis. Similarly, the exposure of the urinary microbiota to antibiotics might generate an alteration in the urinary microbial community.
5.2 Hormonal Status and Menopause
As estrogen levels decrease in menopause, changes occur in the local urogenital tract including thinning of the vaginal epithelium, an increase in pH, and an alteration of the composition of the local bacterial community including a decrease in the typically predominant lactobacilli. In conjunction with declining estrogen levels, a subset of postmenopausal women experience bothersome lower urinary tract symptoms such as burning with urination, urinary urgency, incontinence, and recurrent urinary tract infections. Increased vaginal pH caused by reduced estrogen alters the vaginal microbiome, resulting in reduced levels of Lactobacillus. Such changes influence the vaginal structure and functions, contributing to the onset of genitourinary syndrome of menopause.
Research into postmenopausal urinary microbiome differences has found distinct shifts: a differential abundance analysis showed that the genus Prevotella was significantly dominant in postmenopausal women with genitourinary syndrome of menopause who reported urinary symptoms, and Prevotella was marginally correlated with voiding symptoms.
5.3 Age and Sex
No bacterial species were identified in 30.9% of male participants and 8.1% of female participants in one large asymptomatic cohort. The total number of species detected was 66, with a mean number of species of 1.2 per male and 2.3 per female. UTI microbial communities showed differences according to age, with younger individuals dominated by Escherichia coli and older patients with high abundances of Pseudomonas.
5.4 Diet
Many factors can influence the urinary microbiome, such as age, sex, dietary habits, infections and antimicrobial use, hormonal status, and regional variation. Diet plays a significant role in microbiome health. Foods rich in fiber, vitamins, and minerals support beneficial bacteria throughout the body. Limiting excessive sugar and processed foods can help prevent the overgrowth of harmful organisms that may contribute to infections.
5.5 Underlying Health Conditions
Other factors that may influence the urinary microbiome include diet, stress levels, certain medications, underlying health conditions like diabetes, and practices related to personal hygiene. Urinary incontinence and urgency urinary incontinence or overactive bladder are very common, but not clearly understood, conditions characterized by urgency, frequency, and urinary incontinence that mainly affect women and the elderly. Risk factors may be obesity, menopause, poor pelvic floor tone, multiple natural childbirths, excessive consumption of stimulants such as caffeine and taurine, cigarette smoke, and urological interventions.
5.6 Gut Microbiome Connection
The complex interaction between the gut and urinary microbiota underscores the importance of understanding microbial dysbiosis in urinary tract infection. Research has established the gut as a reservoir for uropathogens; dysregulation of gut flora can predispose individuals to urinary dysbiosis.
6. Nutrients, Herbs, and Natural Ingredients
6.1 Cranberry (Vaccinium macrocarpon)
Traditional Use
Cranberry products have been used in folk and traditional medicine across North America for urinary tract support for many centuries. Cranberry products have been used widely for several decades to prevent urinary tract infections. Indigenous and traditional North American medical traditions employed both cranberry juice and preparations for urinary discomfort and infections.
Scientific Evidence
Cranberries contain proanthocyanidins (PACs), which inhibit the adherence of p-fimbriated Escherichia coli to the urothelial cells lining the bladder. The anti-adhesion mechanism operates through both PACs and fructose: proanthocyanidin (PAC) binds to the adhesin molecule PapG on type P pili and inhibits uropathogenic E. coli (UPEC) adhesion to the epithelial cells that line the urinary tract, while fructose and D-mannose bind to FimH residues on type 1 pili, thus reducing bacterial adhesion to the urothelium.
A landmark 2023 Cochrane systematic review and meta-analysis — the fifth update of a review first published in 1998 — evaluated 50 randomized controlled trials including 8,857 participants. It concluded that cranberry is beneficial for symptomatic, culture-verified UTIs in women with recurrent UTIs, in children, and in people susceptible to UTIs following interventions. Across studies, cranberry products reduced the risk of UTIs (6,211 participants: RR 0.70, 95% CI 0.58 to 0.84).
The role of PAC dose has been further investigated. A separate meta-analysis of 10 RCTs found that when the daily intake of PACs was at least 36 mg, the risk of UTIs was reduced by 18% (RR = 0.82, 95% CI = 0.69–0.98, p = 0.03). This meta-analysis confirmed the ability of daily cranberry intake for UTI prevention in these groups, but there were different PAC intakes in each study, making it difficult to identify the optimal daily PAC level needed to prevent UTI recurrence.
Evidence strength: Moderate certainty for prevention of symptomatic, culture-verified UTIs in women with recurrent UTIs, children, and post-intervention patients. Evidence quality is rated moderate due to heterogeneity of cranberry formulations, dosing regimens, and populations studied. There is currently no established regimen for what PAC dose to use, and no formal regulation by health authorities of cranberry products.
6.2 D-Mannose
Traditional Use
D-mannose is a naturally occurring simple sugar found in many fruits, including cranberries, apples, and peaches. Its use specifically for urinary tract support is a relatively recent development in natural-health practice, arising primarily in the late 20th century rather than from a long-established herbal tradition.
Scientific Evidence
Type 1 pilus ends with a FimH adhesin molecule at the tip which usually binds to highly N-mannosylated uroplakin proteins abundantly expressed on the apical surface of the urothelium. Fructose and D-mannose bind to the FimH residues, thus reducing bacterial adhesion to the urothelium.
A 2022 systematic review of clinical trial outcomes for D-mannose in women noted: there is low-level evidence, from a small number of studies, supporting the use of D-mannose or combination treatments for potentially preventing UTIs in adult women without producing burdening side effects; however, larger and more randomized double-blinded trials are needed to confirm this. Multiple studies of cranberry produced conflicting evidence regarding their effectiveness.
A literature review captured all studies through 2023 and found limited data for D-mannose and vitamin C, and randomized data for cranberry as defined by the classification system. The three supplements reviewed appear not to be strongly supported by clinical data.
Evidence strength: Preliminary and low-certainty. The mechanistic rationale is well established in vitro, but the number of adequately powered human RCTs remains small. D-mannose warrants further investigation in large, blinded trials.
6.3 Probiotics and Lactobacillus Strains
Traditional Use
The concept of enriching the diet with Lactobacillus organisms to restore microbial balance was proposed as early as the early 20th century. As early as 1908, the concept of a healthy microbiota was proposed by Metchnikoff with his suggestion of enriching the diet with a species of Lactobacillus thought to be beneficial in the human gut. Fermented dairy products and traditional fermented foods have served as delivery vehicles for lactobacilli across many cultures.
Scientific Evidence
Probiotics are defined as "a preparation of, or a product containing viable, defined micro-organisms in sufficient numbers, which alter the microflora (by implantation or colonisation) in a compartment of the host and by that exert beneficial health effects in this host." Probiotic organisms such as Lactobacillus are thought to establish a barrier against infectious pathogens ascending the urinary tract, colonizing, and subsequently causing infection.
Specific strains have been studied. Evidence has been found that Lactobacillus species — particularly L. rhamnosus GR-1 and L. reuteri — may be useful in the prevention and treatment of recurrent UTIs. A double-blind study demonstrated that supplementation with L. rhamnosus GR-1 and L. reuteri RC-14 significantly though incompletely decreased the mean number of recurrences in patients with uncomplicated UTI relative to the control.
Lactobacillus strains isolated from female urogenital samples have routinely exhibited antimicrobial properties, suggesting that they play a role in inhibiting or killing pathogens in the urinary tract and/or vagina.
A Cochrane systematic review on probiotics for preventing UTIs in adults and children reached a cautious conclusion. Overall, lactobacilli were beneficial for the treatment of patients with bacterial vaginosis. No clear benefit was seen for candidiasis or urinary tract infection. Studies were heterogeneous, with some limited by small population size. The use of certain lactobacillus strains such as L. rhamnosus GR-1 and L. reuteri for prevention and treatment of recurrent urogenital infection is promising, especially for recurrent bacterial vaginosis. Scant data on the use of probiotics for urinary tract infection and vulvovaginal candidiasis precludes definitive recommendations.
Further clinical trials involving large numbers of patients will be mandatory to achieve definite evidence of the preventive and curative role of probiotics in UTIs. Details about correct formulations in terms of amount of bacteria, viability, and associated growth factors will be required in order to standardize the administration schedule and achieve homogeneous and comparable results.
Regarding the postmenopausal context: Hormone replacement therapy is known to restore the health of the genitourinary microbiome in part. Women with genitourinary syndrome of menopause could be potentially treated by supplementation with estrogen or Lactobacillus, or probably a combination of both.
Evidence strength: Mixed. While mechanistic and preliminary clinical data support the role of specific strains — particularly L. rhamnosus GR-1 and L. reuteri — in reducing recurrent UTI episodes, the evidence base for urinary-specific probiotic intervention remains limited by small sample sizes and study heterogeneity. It is stronger for vaginal/urogenital health broadly than for the bladder microbiome specifically.
6.4 Uva Ursi (Arctostaphylos uva-ursi, Bearberry)
Traditional Use
Bearberry leaves have been used by the indigenous people of America for centuries to treat urinary tract infections. Uva ursi is an herbal extract derived from the leaves of Arctostaphylos, a small evergreen shrub, which has been used in Native American traditional medicine for treatment of urinary tract symptoms and as a diuretic. Uva ursi has been used to treat dysuria, cystitis, urethritis, and kidney and bladder stones. It has also been recommended for inducing diuresis and to treat constipation.
In European herbal medicine, uva ursi has been used extensively and is listed in the pharmacopoeias of many Western societies for the treatment of urinary conditions, primarily symptoms of urinary tract infection. From 1820 to 1936, a fluid extract made from the leaves of the herb was listed as a urinary antiseptic in the US Pharmacopeia and US National Formulary. The leaf extract of Arctostaphylos uva-ursi has been approved for use for urinary tract inflammation by the German Federal Institute for Drugs and Medical Devices and is available on prescription in Germany for this indication.
Phytochemistry and Proposed Mechanism
Uva ursi leaves contain several phytochemicals, including ursolic acid, tannic acid, gallic acid, oils, resins, hydroquinone glycosides (mainly "arbutin"), and flavonoids. The active component of uva ursi is suspected to be hydroquinone, and particularly arbutin and methyl arbutin, which may have anti-inflammatory and antiseptic activities that are excreted in the urine. In-vitro studies have demonstrated antibacterial activity against a variety of organisms including Escherichia coli, the most prevalent urinary pathogen. The antimicrobial action has been attributed to the hydroquinone derivatives, especially arbutin.
An important pH-dependent factor governs its bioactivity: arbutin conversion to free hydroquinone depends heavily on urinary pH. In highly acidic urine, the enzymatic cleavage is reduced, and less free hydroquinone reaches the urinary epithelium.
Scientific Evidence
While uva ursi has been used extensively in traditional medicine, there is no convincing medical evidence that it is effective in treating urinary tract infections or urinary symptoms. Herbal products for the relief of urinary symptoms are widely available over-the-counter with a traditional-use licence, although they have never been subjected to rigorous efficacy studies. Uva ursi leaf is listed by the European Medicines Agency's Herbal Medicinal Products Committee as a traditional herbal medicinal product for short-term relief of mild recurrent lower urinary tract symptoms in adults, once serious conditions have been excluded.
Evidence strength: Very limited. Evidence remains principally from in vitro and traditional-use records. No large, rigorous RCTs have established clinical efficacy. Regulatory status in Europe is as a "traditional herbal medicinal product" — a lower evidential bar than full medicinal product authorization. The EMA listing does not imply proven clinical efficacy comparable to pharmaceutical standards.
6.5 Vitamin C (Ascorbic Acid)
Traditional Use
Vitamin C-rich foods — citrus fruits, berries, and vegetables — have long been regarded in folk health traditions as beneficial for urinary health, primarily through a theorized urine-acidifying effect.
Scientific Evidence
Urinary tract infections, which predominantly affect women, are linked to alterations in the genitourinary microbiome. Cranberries, rich in proanthocyanidins, and ascorbic acid (vitamin C), known for their urinary acidification properties, are commonly used for UTI prevention. A 2025 pilot RCT directly examined the effect of ascorbic acid supplementation on the urinary microbiome of healthy women in their reproductive years using 16S rRNA amplicon sequencing, though results on microbiome composition changes remain to be fully characterized.
However, the theoretical foundation for urine acidification by vitamin C is contested: while commonly believed to be a potent urinary acidifier, the effect of supplemental vitamin C on urine pH is often limited and inconsistent in healthy individuals. The kidneys have a robust system for regulating the body's acid-base balance, which often overpowers the mild acidity of ascorbic acid.
A 2023 literature review found limited data for vitamin C as a UTI prophylactic. The three supplements reviewed — cranberry, D-mannose, and vitamin C — appear not to be strongly supported by clinical data.
Evidence strength: Weak and inconsistent for direct urinary microbiome modulation or reliable UTI prevention. The proposed mechanism (urine acidification) is physiologically limited. High-dose supplemental vitamin C also carries a risk of increased urinary oxalate, which may be relevant to stone-forming risk.
7. Dietary and Lifestyle Factors
7.1 Hydration
Staying well-hydrated is one of the most effective ways to support urinary health. Adequate fluid intake helps flush harmful bacteria from the system while maintaining optimal conditions for beneficial microorganisms. Mechanistically, the continued removal of urine from the organism does not favor the growth of microorganisms, and regular voiding supports natural mechanical flushing of the urethra.
7.2 Dietary Pattern and Sugar Intake
Diet plays a significant role in microbiome health. Foods rich in fiber, vitamins, and minerals support beneficial bacteria throughout the body. Limiting excessive sugar and processed foods can help prevent the overgrowth of harmful organisms that may contribute to infections. The relationship between dietary patterns and the specific urinary microbiome composition is an area of ongoing study; precise dietary recommendations directly targeting the urobiome await further human trial data.
7.3 Fermented Foods and Dietary Lactobacillus Sources
Lactobacilli — the genus most associated with a healthy urinary flora in women — are present in fermented dairy and plant-based foods such as yogurt, kefir, kimchi, and sauerkraut. While direct clinical evidence linking consumption of such foods specifically to improved urinary microbiome composition is limited, these foods are established dietary sources of viable lactobacilli organisms broadly associated with mucosal health.
7.4 Hormonal Factors and Dietary Phytoestrogens
Menopause represents a key transitional phase in women's health, characterized by declining estrogen levels and increased risk for cardiometabolic, musculoskeletal, and urogenital disorders. Beyond its endocrine roots, emerging evidence highlights the gut microbiome as a critical modulator of systemic hormonal balance. Dietary phytoestrogens (found in soy, flaxseed, and legumes) interact with the gut "estrobolome" and influence systemic estrogen metabolism; evidence from current studies reveals distinct findings across populations, reflecting the complexity of estrogen regulation in part by the gut microbiome.
7.5 Stimulants, Lifestyle, and Other Factors
Risk factors for urinary incontinence and overactive bladder — conditions associated with urinary flora dysbiosis — may include obesity, menopause, poor pelvic floor tone, multiple natural childbirths, excessive consumption of stimulants such as caffeine and taurine, cigarette smoke, and urological interventions. Even something as simple as holding urine for extended periods can affect the bacterial balance in the urinary tract.
7.6 Gut Microbiome Support as an Indirect Urinary Health Strategy
The intricate relationship between the gut and the urinary microbiota underscores the importance of understanding microbial dysbiosis. This is particularly crucial for children with congenital malformations of the urinary tract, who are at risk of developing UTIs due to the complex interplay of host and microbial factors. For the general population, maintenance of gut microbial diversity through varied fiber intake, avoidance of unnecessary antibiotics, and dietary probiotic foods is likely to support the gut-urinary microbiome axis, though direct urinary microbiome effect data are still emerging.
8. Current State of Research and Limitations
Association between dysbiosis and various diseases, including inflammatory, autoimmune, and neurodegenerative diseases, has been established, but the question remains whether dysbiosis is a cause or consequence of disease. Merely having information about microbial community changes does not specify whether those changes are functionally detrimental to the host, secondary outcomes from diseases, or individual host-related factors. Future research should focus not only on correlating urinary microbiome changes to diseases but also on interactions between the host and microbiome, such as the impact of imbalanced urobiomes on host functions (e.g., the immune system, glomerular filtration), and on host factors that influence the microbiome.
There are differences according to the urine collection method, 16S rRNA analysis tools, statistical methods, and the taxonomic database on which the reporting of genera or species is based. These heterogeneous study designs cause discrepancies in results. The field is further limited by the low biomass of the urinary microbiome compared with gut samples, making amplification-based sequencing vulnerable to contamination artifact.
References
Go back